Effectiveness, Tolerability, and Safety of Different Amphotericin B Formulations in Invasive Fungal Infections: A Multicenter, Retrospective, Observational Study

Francelise Bridi Cavassin(Faculdade de Administração Ciências Educação e Letras), Flávio Queiroz‐Telles(Hospital de Clínicas Universidade Federal do Paraná), Fábio de Araújo Motta(Hospital Erasto Gaertner), Diego R. Falci(Hospital de Clínicas de Porto Alegre), Fabianne Carlesse(Support group for adolescents and children with cancer), Carla Sakuma de Oliveira(Hospital Universitário Regional do Norte do Paraná), Giovanni Luís Breda(Radboud University Nijmegen), Hugo Manuel Paz Morales(Hospital Erasto Gaertner), João Luiz Baú-Carneiro, Marcello Mihailenko Chaves Magri(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), José Ernesto Vidal(Instituto de Infectologia Emílio Ribas), Talita Teles Teixeira Pereira(Hospital São Rafael), Maíra Araujo Félix(Instituto de Infectologia Emílio Ribas), Patrícia Silva Montes(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Mirela Pereira Lima Abrão(Universidade Federal de Goiás), Renata de Bastos Ascenço Soares(Instituto Nacional de Ciência e Tecnologia de Doenças Tropicais), Julia Raquel da Silva do Ó(Pontifícia Universidade Católica de Goiás), Ana Verena Almeida Mendes(Escola Bahiana de Medicina e Saúde Pública), Caroline Martins Rego(Instituto de Infectologia Emílio Ribas), Paula Pacheco Katopodis(Pontifícia Universidade Católica de Goiás), Cássia Silva de Miranda Godoy(Instituto Nacional de Ciência e Tecnologia de Doenças Tropicais), Mariane Taborda(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo)
Clinical Therapeutics
February 24, 2024
10.1016/j.clinthera.2024.01.011
Cited by 10

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
|The Lancet|2022|467
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology
|The Lancet Infectious Diseases|2021|450
Chromoblastomycosis
|Clinical Microbiology Reviews|2016|339